When was GenScript founded?

GenScript was founded in 2002 and raised its 1st funding round 7 years after it was founded.

Where is GenScript located?

GenScript is headquartered in Piscataway, United States. It is registered at Piscataway, New Jersey.

How many employees does GenScript have?

As of Sep 30, 2026, the latest employee count at GenScript is 1375.

Is GenScript a funded company?

GenScript is a funded company, having raised a total of $***** in its 1st and only funding round, a Series A round on Jun 23, 2009.

When was the latest funding round of GenScript?

GenScript's latest funding was a $***** Series A round on Jun 23, 2009, with participation from 1 investor.

Where does GenScript rank among its competitors?

GenScript ranks 7th amongst 1466 active competitors, of which 78 are funded. It stands 5th in terms of total funding among its competitors. The most recent competitor to raise funding was BioLamina, which secured $23.6M in Apr, 2026.

Who are the top competitors of GenScript?

GenScript's top competitors include Abcam, Meridian Bioscience and Sino Biological. Among them, BioLamina secured the most recent funding round in April, 2026.

GenScript - 2026 Company Profile, Funding & Competitors

Company Details

Provider of reagents and instruments for life sciences research. It provides a portfolio of services that include Bio-reagent, Bio-assay, lead optimization, and antibody drug development. Along with this, the company focuses on CRISPR reagents and reagents for CRISPR/CAS9 genome editing in particular. Additionally, the product line comprises several bioinformatics tools as well, such as the Molecular biology tool, Peptide tool, and protein tool.

Website: www.genscript.com/
Social
Registered Address: Piscataway, New Jersey

Key Metrics

Founded Year

2002

Location

Piscataway, United States

Stage

Public

Total Funding

$15M in 1 round

Latest Funding Round

Series A, Jun 23, 2009, $*****

Investors

Kleiner Perkins & 2 more

Ranked

7^th among 1466 active competitors

Employee Count

1,375 as on Sep 30, 2026

Investment & Acquisitions

CustomArray

Similar Companies

Sino Biological & 646 more

Exit Details

Public

View GenScript's full profile

GenScript is associated with 2 legal entities given below:

Legal Entity Name	Date of Incorporation	Revenue	Latest Employee Count	Reports
GenScript Inc. CIN: 36-4654831 , United States, Active	Dec 31, 2001	-	5260 (As on Dec 31, 2021)	-
GENSCRIPT USA INCORPORATED CIN: 364654831 , United States, Active	Dec 31, 1999	-	554 (As on Dec 31, 2024)	-

GenScript got listed on Dec 30, 2015.

Click here to take a look at GenScript's IPO in detail

GenScript has raised a total funding of $15M over 1 round. Its latest funding round was a Series A round on Jun 23, 2009 for $*****. 1 investor participated in its latest round. GenScript has 3 institutional investors.

Here is the list of recent funding rounds of GenScript:

Date of Funding	Funding Amount	Round Name	Post-Money Valuation	Revenue Multiple	Lead Investors	Other Investors
Jun 23, 2009	1787453	Series A	2206313	6081068	3574999	7093501

Access funding benchmarks and valuations. Sign up today!

View details of GenScript's funding rounds and investors

GenScript's employee count trend

GenScript has 1,375 employees as of Sep 26. Here is GenScript's employee count trend over the years:

Uncover GenScript's growth story! Sign up today!

Access Tracxn on any website

Our Google Chrome extension lets you view company details while browsing their websites

Install Tracxn Extension

Top competitors of GenScript include Abcam, Meridian Bioscience and Sino Biological. Here is the list of Top 10 competitors of GenScript, ranked by Tracxn score:

Rank	Company Details	Short Description	Total Funding	Investors	Tracxn Score
1st	Abcam 1998, Cambridge (United Kingdom), Acquired	Developer of biological reagents for life science research	$78.8M	Juno Investment Partners, Martlet Capital ... & 2 others	73/100
2nd	Meridian Bioscience 1976, Ohio (United States), Acquired	Molecular diagnostic device and kits	-	JobsOhio, NIH	67/100
3rd	Sino Biological 2007, Beijing (China), Series A	Provider of reagents,and kits for clinical research	$29.4M	Qiming Venture Partners, CTS Capital & 1 others	63/100
4th	Huwel Life 2015, Hyderabad (India), Series A	Molecular diagnostic solutions and products for the healthcare industry	$5.74M	Bartronics, BIRAC & 3 others	63/100
5th	Devyser 2004, Stockholm (Sweden), Public	Provider of molecular diagnostic kits for cancer, hereditary diseases, and reproductive disorders	$15.5M	Swedbank Robur, Fjarde AP-fonden & 1 others	61/100
6th	Miltenyi Biotec 1989, Bergisch Gladbach (Germany), Funding Raised	Develops tools and products for research and clinical application	-	Europa, HHS	61/100
7th	GenScript 2002, Piscataway (United States), Public	Provider of reagents and instruments for life sciences research	$15M	Kleiner Perkins, Vermögensclub & 1 others	58/100
8th	BioLamina 2008, Sundbyberg (Sweden), Series B	Cell culture reagents for stem cell research	$18.2M	Lauxera Capital Partners, Bure Equity & 5 others	58/100
9th	Teknova 1996, Hollister (United States), Public	Provider of molecular biology research reagents and kits	-	Cambrian Growth Partners, Telegraph Hill Partners ... & 2 others	58/100
10th	Stem Cell Technologies 1993, Vancouver (Canada), Series A	Developer of cell culture media and ancillary reagents for life science research	$11.9M	National Research Council Canada, BDC & 1 others	58/100